A 38-year-old patient with refractory major depression has b… | MyMerci
Medical Emergencies PA
Question

A 38-year-old patient with refractory major depression has been taking fluoxetine 20 mg PO daily for 4 weeks but reports no improvement. The prescriber plans to transition to tranylcypromine. Which patient teaching reflects safe transition?

Explanation
Combining a serotonergic SSRI with a MAOI causes serotonin syndrome — a potentially fatal triad of mental status change, autonomic instability, and neuromuscular hyperactivity. The standard rule before starting a MAOI is 14 days off most antidepressants, but 5 weeks (≥35 days) off fluoxetine because of its long-acting active metabolite norfluoxetine (half-life 7–15 days). When the MAOI is started, the patient also begins the tyramine-restricted diet (no aged cheese, cured meats, fermented soy, draft beer, red wine, fava beans, etc.), avoids sympathomimetic OTCs, and carries a MAOI wallet card. Same-day, overlap, or no-washout strategies all create a dangerous serotonergic stack.

In-depth explanation

Other MAOI washout: 14 days from sertraline, paroxetine, escitalopram, citalopram, venlafaxine, duloxetine, TCAs; 5 weeks from fluoxetine; 24 hours from SSRIs to most other antidepressants is NOT enough when transitioning to a MAOI.

Clinical scenario

Scenario 38-year-old, refractory MDD, on fluoxetine 20 mg PO daily for 4 weeks with no symptomatic response. Prescriber plans to switch to tranylcypromine. No SI/HI today, no medical contraindications, normal LFTs and BP, and willing to follow dietary restrictions. Other meds: oral contraceptive, multivitamin. No OTC decongestants.

Key concepts

Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free
Read in another language: English한국어日本語繁體中文Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.